High incidence of amyotrophic lateral sclerosis in the Faroe Islands 2010–2020

Research output: Contribution to journalJournal articlepeer-review


  • Fulltext

    Final published version, 353 KB, PDF document

  • Malan Johansen
  • Kirsten Svenstrup
  • Poul Joensen
  • Bjarni Steig
  • Guðrið Andorsdóttir
  • Hansen, Torben
  • Maria Skaalum Petersen

The Faroese population isolate harbors epidemiological and genetic characteristics that likely differ from outbred populations. This population-based register study found that the Faroese 2010–2020 crude incidence of amyotrophic lateral sclerosis (ALS) was 4.9/100,000 person-years (95% confidence interval [CI], 3.3–7.0) and the age- and sex-standardized incidence (US 2010 Census Population) was 4.1/100,000 person-years (95% CI, 2.7–6.0), which is a 68% increase from the 1987–2009 estimate. The 2020 crude prevalence was 9.5/100,000 (95% CI, 3.0–19.6) in a population of 52,912 inhabitants. Incidence and prevalence estimates of ALS in the Faroes are high and further research is warranted to uncover the genetic or environmental determinants of ALS in this population.

Original languageEnglish
JournalAnnals of Clinical and Translational Neurology
Issue number2
Pages (from-to)227-231
Publication statusPublished - 2022

Bibliographical note

Publisher Copyright:
© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

ID: 290596931